Navigation Links
Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
Date:11/30/2009

NEW YORK, Nov. 30 /PRNewswire/ -- Stemline Therapeutics, Inc., a private clinical stage biopharmaceutical company and leading developer of oncology compounds directed to cancer stem cells, today announced that The University of Texas M.D. Anderson Cancer Center (Houston, TX) and Stemline have entered into a research collaboration. As part of this collaboration, M.D. Anderson has joined an ongoing Phase I/II clinical trial of SL-401 in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

"We are pleased to be involved with Stemline and its innovative programs targeting cancer stem cells," said Hagop Kantarjian, MD, Chairman of the Department of Leukemia at M.D. Anderson. "This clinical trial provides a new option for our patients with AML and MDS."

Stemline's CEO, Ivan Bergstein, MD, said. "We are very pleased to have M.D. Anderson, a world class institution and leader in oncology, join the ongoing Phase I/II study in AML and MDS for SL-401 and work with us on additional programs. This is an exciting time for the company as we expand our clinical program, advance our diverse pipeline, and continue to build out our proprietary platforms."

About Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor which is expressed on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I/II clinical trial. Stemline is also developing a proprietary portfolio of biological and small molecule compounds directed at high value cancer stem cell targets of a variety of hematological and solid cancers. Stemline has built a robust discovery platform called StemScreen® which t
'/>"/>

SOURCE Stemline Therapeutics, Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Echo Therapeutics to Present at the New York Society of Security Analysts 13th Annual Biotech and Specialty Pharmaceuticals Conference
2. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
3. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
4. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
5. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
6. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
7. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
8. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
9. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
10. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
11. Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses ... non-profit substance abuse services organization, is hosting its tenth ... Hills Hotel on June 6, 2013.  More than 300 ... funds for the adolescent residential treatment centers, family therapy, ... honor individuals whose accomplishments have positive influences on the ...
(Date:5/24/2013)... Solta Medical, Inc. (NASDAQ: SLTM ), a global ... Edward W. Knowlton has resigned as a ... Knowlton is the founder of Thermage, the predecessor company to ... "On behalf of the entire Board of Directors, ... thank Ed for his tireless dedication to our company and ...
(Date:5/24/2013)... 24, 2013  An international roster of experts on ... in Santa Monica, Calif. , to ... for MPM, a rare form of cancer that results ... the lining of the chest. Hosted by ... the 3rd Annual International Symposium on Lung-Sparing Therapies for ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3
... 21 /PRNewswire/ Terumo Heart, Inc. today,announced the discharge of ... Assist System (LVAS). The patient was,discharged home on August ... after receiving the device., The patient is a ... heart failure for nearly 20 years. He is the ...
... have a study,that is falling behind with recruitment? Have ... media but still have not seen the,desired results? Perhaps ... to help,your sites navigate the world of media placements ... Argonauta Assist(TM) service," says Ms. Ann Kottcamp,President of Argonauta ...
Cached Medicine Technology:Discharge of First U.S. DuraHeart(TM) Patient 2Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
(Date:5/24/2013)... (May 24, 2013) The news about youth and diabetes ... diabetes study shows that children who develop Type 2 diabetes ... problems faster and at a higher rate than people who ... kids have Type 2 diabetes, they seem to be at ... said Jane Lynch, M.D., professor of pediatric endocrinology in the ...
(Date:5/24/2013)... 2013 Fit Yummy Mummy, a fitness ... who are trying to get rid of the belly ... ideal for women who want to combine exercises with ... ’s Stan Stevenson, prompting an investigative review. , “Holly's ... a wide variety of motivational strategies, nutritional plans, proper ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... nutrition school, is happy to announce that it has donated ... that supports the women held captive in Cleveland, Ohio. , ... Gina de Jesus, Michelle Knight, and Amanda Berry and her ... captive for a decade, we were shocked and horrified,” said ...
(Date:5/24/2013)... May 24, 2013 General Data ... barcode identification, tracking and data management products and ... Biomedical Sciences Inc., (TBS) of Durham, North Carolina, ... and consumables for the clinical and research pathology ... Data Healthcare, which provides specialty products and solutions ...
(Date:5/24/2013)... help schizophrenics? Finding the answer for this is at the ... Researchers from the Bergen fMRI Group at the University of ... hear voices. The way they do this is by studying ... from a mental illness. For a five-year period, the group ... A recent report published in Frontiers in Human Neuroscience ...
Breaking Medicine News(10 mins):Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2
... By Denise Mann HealthDay Reporter , MONDAY, Jan. ... high-volume hospitals may fare better than those who are treated ... but this is not due to volume alone. New ... spot and handle complications should they occur after heart surgery. ...
... faces are everywhere. Whether it,s New Hampshire,s erstwhile granite "Old ... our brains are adept at locating images that look like ... into thinking such objects actually are human faces. "You ... on the other hand, you,re not misled into believing that ...
... 2011 The pathology of Parkinson,s disease is characterized by ... the substantia nigra (SN), an area of the brain associated ... protein in the form of Lewy bodies (LB) in the ... thought to progress along with the clinical course of Parkinson,s ...
... agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity ... single pharmacologic agent. A recent study by Dr. Timothy ... issue of the Journal of the American Academy ... first randomized placebo-controlled trial designed to assess efficacy and ...
... Center researchers identified a new culprit that leads to ... into plaque and narrows arteries. The research, published online ... explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, ... macrophages that accumulate in plaques secrete a molecule called ...
... (HealthDay News) -- Most parents who have genetic tests for ... new study finds. Researchers interviewed 253 parents who underwent ... (BRCA1 and BRCA2) that can be inherited. All the participants ... the genetic test. Twenty-nine percent of the parents were ...
Cached Medicine News:Health News:Kids Who Need Heart Surgery May Fare Better at Busier Hospitals 2Health News:MIT: How does our brain know what is a face and what's not? 2Health News:MIT: How does our brain know what is a face and what's not? 3Health News:New study supports view that Lewy bodies are not the primary cause of cell death in PD 2Health News:Combination therapy shows positive response for children with ADHD 2Health News:Researchers discover new culprit in atherosclerosis 2Health News:Most Parents Tell Kids About Test Results for Breast Cancer Genes 2
... Protection System helps protect infants, patients, staff, ... operating efficiencies, cost savings, and overall peace ... and constrained healthcare facilities., And with HALO, ... and versatile solution, but also unique-skin sensing ...
... enables immediate infant location ... door locking and abduction ... match infants to their ... switching, secure their safety ...
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... medicine is the ability of medical equipment, ... ways based on what is happening around ... a Radianse indoor positioning solution (IPS) establishes ... requires identity, location and time to be ...
Medicine Products: